These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 707588)
21. Insulin treatment and state of control before, during, and after connection to a glucose controlled insulin infusion system (Biostator). Christiansen JS; Svendsen PA; Deckert T Horm Metab Res Suppl; 1979; (8):131-4. PubMed ID: 395069 [TBL] [Abstract][Full Text] [Related]
22. Experiences of continuous subcutaneous insulin infusion in pregnant women with type 1 diabetes during delivery from four Italian centers: a retrospective observational study. Fresa R; Visalli N; Di Blasi V; Cavallaro V; Ansaldi E; Trifoglio O; Abbruzzese S; Bongiovanni M; Agrusta M; Napoli A Diabetes Technol Ther; 2013 Apr; 15(4):328-34. PubMed ID: 23537417 [TBL] [Abstract][Full Text] [Related]
23. [Insulin-dependent diabetes and pregnancy. A model of coordinated approach]. Gamba S; Barolo P; Blatto A; Grassi G; Carlini M; Winkler T; Zanno C; Bianciotto F; Guala G; Gandolfo MT Ann Osp Maria Vittoria Torino; 1986; 29(1-6):127-64. PubMed ID: 3324885 [TBL] [Abstract][Full Text] [Related]
24. The effect of hyperglucagonemia on blood glucose concentrations and on insulin requirements in insulin-requiring diabetes mellitus. Clarke WL; Santiago JV; Kipnis DM Diabetes; 1978 Jun; 27(6):649-52. PubMed ID: 658610 [TBL] [Abstract][Full Text] [Related]
25. Pregestational diabetes: insulin requirements throughout pregnancy. Langer O; Anyaegbunam A; Brustman L; Guidetti D; Levy J; Mazze R Am J Obstet Gynecol; 1988 Sep; 159(3):616-21. PubMed ID: 3048099 [TBL] [Abstract][Full Text] [Related]
26. Pronounced insulin resistance and inadequate beta-cell secretion characterize lean gestational diabetes during and after pregnancy. Kautzky-Willer A; Prager R; Waldhausl W; Pacini G; Thomaseth K; Wagner OF; Ulm M; Streli C; Ludvik B Diabetes Care; 1997 Nov; 20(11):1717-23. PubMed ID: 9353615 [TBL] [Abstract][Full Text] [Related]
27. Comparison of a perfusion syringe (Mill Hill Infusor) and a glucose-controlled insulin infusion system in the regulation of diabetes mellitus. Stavljenić A; Granić M; Topić B; Skrabalo Z Horm Metab Res Suppl; 1979; (8):207-11. PubMed ID: 395083 [TBL] [Abstract][Full Text] [Related]
28. A glucose-controlled insulin infusion system for diabetic women during labour. Nattrass M; Alberti KG; Dennis KJ; Gillibrand PN; Letchworth AT; Buckle AL Br Med J; 1978 Aug; 2(6137):599-601. PubMed ID: 698607 [TBL] [Abstract][Full Text] [Related]
29. The effect of three days of blood glucose normalization by means of an "artificial endocrine pancreas" on the concentrations of growth hormone, glucagon, and cortisol in juvenile diabetics. Schock A; Schultz M; Kerner W; Maier V; Pfeiffer EF Horm Metab Res Suppl; 1979; (8):93-6. PubMed ID: 395097 [TBL] [Abstract][Full Text] [Related]
30. White's classification and pregnancy outcome in women with type 1 diabetes: a population-based cohort study. Klemetti MM; Laivuori H; Tikkanen M; Nuutila M; Hiilesmaa V; Teramo K Diabetologia; 2016 Jan; 59(1):92-100. PubMed ID: 26474777 [TBL] [Abstract][Full Text] [Related]
31. Efficacy of the insulin pump in the home treatment of pregnant diabetics. Rudolf MC; Coustan DR; Sherwin RS; Bates SE; Felig P; Genel M; Tamborlane WV Diabetes; 1981 Nov; 30(11):891-5. PubMed ID: 7028543 [TBL] [Abstract][Full Text] [Related]
32. [Assessment of self monitoring of blood glucose (SMBG) and continuous subcutaneous insulin infusion (CSII) in diabetic pregnant women]. Murata K; Toyoda N; Ito M; Rii T; Sugiyama Y; Miyamura Y Nihon Sanka Fujinka Gakkai Zasshi; 1985 Dec; 37(12):2749-57. PubMed ID: 4086905 [TBL] [Abstract][Full Text] [Related]
33. Pregnancy outcome in patients with insulin-dependent diabetes mellitus with preconceptional diabetic control: a comparative study. Goldman JA; Dicker D; Feldberg D; Yeshaya A; Samuel N; Karp M Am J Obstet Gynecol; 1986 Aug; 155(2):293-7. PubMed ID: 3740144 [TBL] [Abstract][Full Text] [Related]
34. Using technology to advance type 1 diabetes care among women during the reproductive years and in pregnancy. Polsky S; Giordano D; Voelmle MK; Garcetti R; Garg SK Postgrad Med; 2016 May; 128(4):418-26. PubMed ID: 26924774 [TBL] [Abstract][Full Text] [Related]
35. Clinical evaluation and preliminary studies on the use of an artificial pancreatic beta cell in juvenile diabetes mellitus. Clarke WL; Thomas L; Santiago JV J Pediatr; 1977 Oct; 91(4):590-6. PubMed ID: 561836 [TBL] [Abstract][Full Text] [Related]
37. [Insulin therapy of patients with diabetes mellitus after abdominal delivery]. Orlov VI; Poliakov VV; Veksler AIa Akush Ginekol (Mosk); 1989 Mar; (3):44-7. PubMed ID: 2660622 [TBL] [Abstract][Full Text] [Related]
38. [Possibility of maintaining optimal metabolic control in pregnant patients with insulin-dependent diabetes]. Micaló T; Sallent N; Gutiérrez A; Noguera J; Figuerola D Med Clin (Barc); 1986 Dec; 87(19):787-90. PubMed ID: 3546971 [No Abstract] [Full Text] [Related]
39. Safety and tolerability of once or twice daily neutral protamine hagedorn insulin in fasting pregnant women with diabetes during Ramadan. Nor Azlin MI; Adam R; Sufian SS; Wahab NA; Mustafa N; Kamaruddin NA; Jamil MA J Obstet Gynaecol Res; 2011 Feb; 37(2):132-7. PubMed ID: 21159037 [TBL] [Abstract][Full Text] [Related]
40. Use of an artificial endocrine pancreas in diabetic pregnancy. Tamás G; Bojta J; Báayai Z; Petrányi G; Szalay J Horm Metab Res Suppl; 1979; (8):166-8. PubMed ID: 395075 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]